Which of the following is given to treat thrombocytopenia secondary to anti-cancer therapy and is known to stimulate progenitor megakaryocytes?

Correct Answer: Oprelvekin
Description: Oprelvekin or recombinant interleukin-11- used in management of chemotherapy-induced thrombocytopenia S/E- fluid retention, hea failure, and arrhythmias. Two drugs that activate the thrombopoietin receptor: Romiplostim Eltrombopag These are used in idiopathic thrombocytopenia.
Category: Medicine
Share:

Get More
Subject Mock Tests

Practice with over 200,000 questions from various medical subjects and improve your knowledge.

Attempt a mock test now
Mock Exam

Take an exam with 100 random questions selected from all subjects to test your knowledge.

Coming Soon
Get More
Subject Mock Tests

Try practicing mock tests with over 200,000 questions from various medical subjects.

Attempt a mock test now
Mock Exam

Attempt an exam of 100 questions randomly chosen from all subjects.

Coming Soon
WordPress › Error

There has been a critical error on this website.

Learn more about troubleshooting WordPress.